相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The 2018 World Health Organization Classification of Cutaneous, Mucosal, and Uveal Melanoma Detailed Analysis of 9 Distinct Subtypes Defined by Their Evolutionary Pathway
David E. Elder et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2020)
Systemic Therapy for Melanoma: ASCO Guideline
Rahul Seth et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients
Bradley N. Greenhaw et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)
Performance of Gene Expression Profile Tests for Prognosis in Patients With Localized Cutaneous Melanoma A Systematic Review and Meta-analysis
Michael A. Marchetti et al.
JAMA DERMATOLOGY (2020)
Prognostic Gene Expression Profiling in Cutaneous Melanoma Identifying the Knowledge Gaps and Assessing the Clinical Benefit
Douglas Grossman et al.
JAMA DERMATOLOGY (2020)
Changes in population-level survival for advanced solid malignancies with new treatment options in the second decade of the 21st century
Dianne Pulte et al.
CANCER (2019)
Survival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study
Antonio Tejera-Vaquerizo et al.
CANCER MEDICINE (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
O. Michielin et al.
ANNALS OF ONCOLOGY (2019)
Head and Neck Melanoma Incidence Trends in the Pediatric, Adolescent, and Young Adult Population of the United States and Canada, 1995-2014
Haley N. Bray et al.
JAMA OTOLARYNGOLOGY-HEAD & NECK SURGERY (2019)
Clinicopathologic, misdiagnosis, and survival differences between clinically amelanotic melanomas and pigmented melanomas
Lauren C. Strazzulla et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Melanoma Staging: American Joint Committee on Cancer (AJCC) 8th Edition and Beyond
Jeffrey E. Gershenwald et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update
Sandra L. Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases
Mario Mandala et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2017)
Towards Personalized Medicine in Melanoma: Implementation of a Clinical Next-Generation Sequencing Panel
de Unamuno Bustos Blanca et al.
SCIENTIFIC REPORTS (2017)
Molecular Melanoma Diagnosis Update Gene Fusion, Genomic Hybridization, and Massively Parallel Short-Read Sequencing
Ursula E. Lang et al.
CLINICS IN LABORATORY MEDICINE (2017)
Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient Management
Ludi Ge et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis
Erin Cordeiro et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Serum lactate dehydrogenase as an early marker for outcome in patients treated with anti-PD-1 therapy in metastatic melanoma
S. Diem et al.
BRITISH JOURNAL OF CANCER (2016)
In-transit Melanoma Metastases: Incidence, Prognosis, and the Role of Lymphadenectomy
Rebecca L. Read et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Rare Presentations of Primary Melanoma and Special Populations A Systematic Review
Lisa A. Kottschade et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2014)
Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease
Augustinus P. T. van der Ploeg et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Lactate dehydrogenase as a selection criterion for ipilimumab treatment in metastatic melanoma
Sander Kelderman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
No benefit in staging fluorodeoxyglucose-positron emission tomography in clinically node-negative head and neck cutaneous melanoma
Jai Bikhchandani et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2014)
Clinicopathologic Predictors of Sentinel Lymph Node Metastasis in Thin Melanoma
Dale Han et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Sentinel Lymph Node Biopsy in Patients With Thin Primary Cutaneous Melanoma
Rajmohan Murali et al.
ANNALS OF SURGERY (2012)
Population-Based 20-Year Survival Among People Diagnosed With Thin Melanomas in Queensland, Australia
Adele C. Green et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Sentinel Lymph Node Biopsy for Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Joint Clinical Practice Guideline
Sandra L. Wong et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
F-18-fluoro-2-deoxyglucose positron emission tomography (PET) and PET/computed tomography imaging in primary staging of patients with malignant melanoma: a systematic review
Milly A. Schroeer-Guenther et al.
SYSTEMATIC REVIEWS (2012)
Clinical Value of Radiographic Staging in Patients Diagnosed With AJCC Stage III Melanoma
Prakash K. Pandalai et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database
John F. Thompson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Sentinel Node Biopsy for Head and Neck Melanoma: A Systematic Review
Nicole de Rosa et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2011)
Final Version of 2009 AJCC Melanoma Staging and Classification
Charles M. Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic factors that determine the long-term survival of patients with unresectable metastatic melanoma
Agop Y. Bedikian et al.
CANCER INVESTIGATION (2008)
Improved survival after lymphadenectomy for nodal metastasis from an unknown primary melanoma
Chris C. Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Yield and predictors of radiologic studies for identifying distant metastases in melanoma patients with a positive sentinel lymph node biopsy
Jason S. Gold et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm
Eve Maubec et al.
MELANOMA RESEARCH (2007)
Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma
Thomas A. Aloia et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma
PB Clark et al.
ARCHIVES OF SURGERY (2006)
Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma
JD Wagner et al.
CANCER (2005)
Early detection of thick melanomas in the United States - Beware of the nodular subtype
MF Demierre et al.
ARCHIVES OF DERMATOLOGY (2005)
Routine imaging of asymptomatics melanoma patients with metastasis to sentinel lymph nodes rarely identifies systemic disease
EP Miranda et al.
ARCHIVES OF SURGERY (2004)
Implications of microscopic satellites of the primary and extracapsular lymph node spread in patients with high-risk melanoma: Pathologic corollary of eastern cooperative oncology group trial E1690
UNM Rao et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Prognostic factors in metastatic melanoma: A pooled analysis of Eastern Cooperative Oncology Group trials
J Manola et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
分享论文
